海利品牌怎么样 申请店铺

我要投票 海利在兽药行业中的票数:413 更新时间:2025-08-24
海利是哪个国家的品牌?「海利」是 上海海利生物技术股份有限公司 旗下著名品牌。该品牌发源于上海,由创始人张海明在1981期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力海利品牌出海!将品牌入驻外推网,定制海利品牌推广信息,可以显著提高海利产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

海利怎么样

上海海利生物技术股份有限公司(以下简称“海利生物”)位于上海奉贤经济开发区金海路6720号,其前身为上海松江生物药品厂,是农业部在上海批准生产兽用生物制品的定点企业及农业部在上海设立的动物重大疫情防治生产基地。作为一家专业的动物保健品公司,海利生物能够为预防动物疾病、改善动物福利和提高养殖业主的生产效益提供综合解决方案。海利生物的产品和服务涵盖了家畜、家禽以及宠物等多个领域。

海利生物是上海市高新技术企业、上海市农业产业化重点龙头企业、上海兽用生物制品工程技术研究中心、上海市科技小巨人(培育)企业;海利生物商标被认定为上海市著名商标,公司的疫苗产品荣获“上海名牌”称号;海利生物为上海农林职业技术学院(生物技术专业)的实习培训基地。

海利生物拥有11条GMP生产线,自主生产家畜、家禽两大系列共40多个产品。多年来,海利生物坚持科技创新之路,以市场为导向、以产品为依托,销售网络遍布全国,销售业绩成倍增长。海利生物现有员工近450名,其中专业技术人员占50%以上。海利生物坚持以人为本的人才战略,已建立起经营高效的管理团队、技术精湛的研发团队以及技能娴熟的员工团队。

在企业快速发展中,海利生物高度重视产、学、研相结合的产品战略,以市场为导向,几年来先后与国内行业领先的中国科学院、中国农科院哈尔滨兽医研究所、南京农业大学、河南农业大学等科研机构合作,共同开发具有国内外先进水平的兽用生物疫苗。特别是拥有了猪繁殖与呼吸综合征活疫苗(即蓝耳病活疫苗)、猪圆环病毒2型灭活疫苗(LG株)、猪传染性胃肠炎和流行性腹泻二联灭活疫苗、猪链球菌二联灭活疫苗、鸡新城疫/传染性支气管炎/减蛋综合征/禽流感(H9N2)四联灭活疫苗等国家一、二类新药的知识产权,其中多个新产品的研发及产业化项目获得了上海市科委、上海市经委的科技创新项目立项支持。海利生物的猪繁殖与呼吸综合征活疫苗(即蓝耳病活疫苗)、猪传染性胃肠炎和流行性腹泻二联灭活疫苗、猪圆环病毒2型灭活疫苗、猪链球菌灭活疫苗、高致病性猪繁殖与呼吸综合征活疫苗已先后被认定为上海市科委高新技术成果转化项目,猪链球菌二联灭活疫苗荣获上海市科技进步二等奖。尤其从2007年开始,在全国范围内爆发的猪蓝耳病疫情防治工作中,海利生物承担了农业部定点生产高致病性猪蓝耳病疫苗的重要任务,为广大养殖户提供优质、可靠的疫苗,及时有效地防控了疫情的蔓延。

海利生物致力于为预防畜禽疾病、改善畜禽健康和提高养殖业主的生产效益服务,并能够提供综合解决方案和权威的兽医专家服务系统。为满足市场需求,海利生物一如既往地坚持自主创新及高新技术产业化发展的战略重点,力争跻身国内兽用生物疫苗行业前列。



Shanghai Haili Biotechnology Co., Ltd. (hereinafter referred to as "Haili biology") is located at No. 6720, Jinhai Road, Fengxian Economic Development Zone, Shanghai. Its predecessor is Shanghai Songjiang biological medicine factory. It is a designated enterprise approved by the Ministry of agriculture to produce biological products for animal use in Shanghai and a production base for animal major epidemic prevention and control established by the Ministry of agriculture in Shanghai. As a professional animal health products company, Haili bio can provide comprehensive solutions for preventing animal diseases, improving animal welfare and improving the production efficiency of breeding owners. Haili's products and services cover livestock, poultry and pets. Haili biology is a high-tech enterprise in Shanghai, a key leading enterprise of agricultural industrialization in Shanghai, a research center of animal biological products engineering technology in Shanghai, and a small giant (cultivation) enterprise of science and technology in Shanghai. Haili biology trademark is recognized as a famous trademark in Shanghai, The company's vaccine products won the title of "Shanghai famous brand"; Haili biology is the practice training base of Shanghai Agricultural and Forestry Vocational Technical College (Biotechnology Major). Haili biological has 11 GMP production lines, and independently produces more than 40 products in two series of livestock and poultry. Over the years, Haili biology adheres to the road of scientific and technological innovation, is market-oriented and product-based, with its sales network all over the country, and its sales performance has multiplied. Haili biology has nearly 450 employees, of which more than 50% are professional technicians. Haili biology adheres to the human-oriented talent strategy and has established an efficient management team, a skilled R & D team and a skilled staff team. In the rapid development of the enterprise, Haili biology attaches great importance to the product strategy of combining production, learning and research, and is market-oriented. In recent years, Haili biology has cooperated with Chinese Academy of Sciences, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Nanjing Agricultural University, Henan Agricultural University and other scientific research institutions to jointly develop animal biological vaccines with advanced level at home and abroad. In particular, it has the knowledge production of the first and second class new drugs in China, such as the live vaccine of porcine reproductive and respiratory syndrome (i.e. the live vaccine of blue ear disease), the inactivated vaccine of porcine circovirus type 2 (LG strain), the inactivated vaccine of swine infectious gastroenteritis and epidemic diarrhea, the inactivated vaccine of Streptococcus suis, the inactivated vaccine of Newcastle disease / infectious bronchitis / egg drop syndrome / avian influenza (H9N2), etc Among them, R & D and industrialization projects of many new products have been supported by science and technology innovation projects of Shanghai Municipal Commission of science and technology and Shanghai Economic Commission. Haili bio's live vaccine for porcine reproductive and respiratory syndrome (i.e. live vaccine for blue ear disease), bivalent inactivated vaccine for transmissible gastroenteritis and epidemic diarrhea, bivalent inactivated vaccine for porcine circovirus type 2, Streptococcus suis, and highly pathogenic live vaccine for porcine reproductive and respiratory syndrome have been successively recognized as the high-tech achievement transformation project of Shanghai Science and Technology Commission, bivalent inactivated vaccine for Streptococcus suis Won the second prize of Shanghai Science and technology progress award. Especially since 2007, in the prevention and control of the outbreak of blue ear disease nationwide, Haili biology has undertaken the important task of producing highly pathogenic blue ear disease vaccine designated by the Ministry of agriculture, providing high-quality and reliable vaccine for the majority of farmers, and preventing and controlling the spread of the disease in time and effectively. Haili biology is committed to the prevention of livestock and poultry diseases, improve the health of livestock and poultry and improve the production efficiency of breeding owners, and can provide comprehensive solutions and authoritative veterinary expert service system. In order to meet the market demand, Haili biology, as always, adheres to the strategic focus of independent innovation and the development of high-tech industrialization, and strives to be in the forefront of domestic veterinary biological vaccine industry.

本文链接: https://brand.waitui.com/5c9756dfe.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

受台风“剑鱼”影响 海口三港口8月23日17时起停运

据“海口发布”官微消息,8月23日11时,海口市交通运输和港航管理局发布一则通告。受今年第13号台风“剑鱼”影响,海口新海港、秀英港和铁路南港将于8月23日17时起停运(指最后发船时间,请至少提前1至2小时到港检票)。预计停运将持续至8月25日上午(具体复运时间视气象情况而定)。有关部门提醒,请有过海需求的司机和旅客合理安排行程,务必提前购票,尽早过海。

2小时前

湾区跨境并购联盟正式成立

8月22日,湾区跨境并购联盟揭牌仪式正式举办,境内外银行、保险、金融性公司资产管理公司(AMC)、金融资产投资公司(AIC)、风投创投、担保公司等金融机构,以及上市公司、产业资本、中介服务机构等50余家联盟成员及相关单位代表共计150余人参会。 当前,全球产业链格局加速重构,跨境并购成为企业技术革新、产业升级、资源配置的重要金融工具。截至2025年8月,年内深圳辖区首次公开披露完成并购交易128单,交易规模合计达到556.96亿元,位居全国大中城市前列。其中全国“首单”跨境换股等业务的成功落地,为行业创新发展提供可复制可推广的“深圳经验”。

2小时前

中国保险资产管理业协会:股票是保险机构下半年首选

中国保险资产管理业协会日前公布了2025年下半年保险资产管理业投资者信心调查结果。本次调查覆盖宏观环境、市场判断、配置计划和收益预期四个方面,共有122家保险机构参与,包括36家保险资产管理机构和86家保险公司。资产配置偏好方面,股票是下半年我国保险机构首选的投资资产,其次是债券和证券投资基金。多数保险机构预期下半年各类资产配置比例与2025年初基本保持一致,部分保险机构有可能适度或微幅增加股票和债券投资。

2小时前

全国新增67所推免资格高校

近日教育部办公厅印发《关于对新增推免资格高校予以备案的通知》,全国新增67所推免资格高校。 今年教育部时隔8年再次启动推免资格高校增选工作。“推免”,即推荐优秀应届本科毕业生免试攻读研究生,是研究生多元招生体系的重要组成部分。其中,“免试”是指普通高校应届本科毕业生不必经过全国硕士研究生入学统一考试的初试,直接进入复试;“推荐”是指普通高等学校按规定对本校优秀应届本科毕业生进行遴选,确认其免初试资格并向招生单位推荐。 按照教育部规定,开展推荐工作的高等学校应教学质量优秀、招生工作秩序良好、办学行为规范;同时,要具有经国务院学位委员会批准的博士学位授予权,或具有经国务院学位委员会批准的硕士学位授予权,且独立招收硕士研究生连续15年(体育、艺术院校连续6年)以上。

2小时前

马斯克:对星舰飞船明年实现完全可重复使用持谨慎乐观态度

SpaceX首席执行官埃隆·马斯克在回复一位X网友讨论火箭发射技术的帖子时称:“制造一种完全可重复使用的轨道火箭是有史以来最难的工程问题之一。比登月难多了,这就是为什么它还没有解决的原因。我对星舰飞船明年将实现完全可重复使用持谨慎乐观态度。另一项关键技术是轨道再填充,尽管要简单得多。如果运气好,明年也会实现。然后我们所知道的意识和生命可以延伸到行星,并进而延伸到恒星。”

2小时前

本页详细列出关于海利的品牌信息,含品牌所属公司介绍,海利所处行业的品牌地位及优势。
咨询